EpLink is the Epilepsy Research Program of the Ontario Brain Institute. We are an epilepsy research program focused on finding new ways to diagnose, treat and improve the lives of people living with drug-resistant epilepsy. Our program is funded by the Ontario Brain Institute and aims to bring health innovations directly to the epilepsy community.
Our vision is a world without epilepsy.
Our mission is to reduce seizures and improve quality of life for people with epilepsy through research.
Our goals are to improve the diagnosis and treatment for drug-resistant seizures and improve the lives of people living with epilepsy. We have over 35 lead researchers working on research projects at eight institutions across Ontario that focus on:
- Diet Therapy
- Epidemiology and Diagnosis
- Genetics and Epigenetics
- Drug Therapy
- Quality of Life
- Brain Monitoring and Modulation
- Seizure Surgery
Through our research we hope to develop more effective drug therapies, improve diet therapies and surgical procedures, uncover new treatment options, such as gene therapy and brain stimulation, and create new programs to improve cognition, mood and quality of life for individuals living with uncontrolled seizures.
EpLink has a Science Innovation Team (SIT) that bring an international perspective and depth of scientific background across disciplines related to epilepsy research. They ensure that EpLink remains innovative and at a high level of scientific excellence.
Our Management Committee
EpLink has a Management Committee that meets every month to advise the EpLink Co-Directors on matters relating to the Program’s governance and function.
W. McIntyre Burnham, PhD
Professor Emeritus, University of Toronto
Mary Pat McAndrews, PhD, C.Psych
Senior Scientist, Krembil Brain Institute
Jorge Burneo, MD, MSPH
Professor of Neurology and Co-Director of the Epilepsy Program, Western University
Amaya Singh, PhD
- Community Advisory Committee
- Drug Development Committee
- Management Committee